Health Technology Assessment (May 2011)

Trastuzumab for the treatment of HER2- positive metastatic adenocarcinoma of the stomach or gastro-oesophageal junction

  • G Norman,
  • S Rice,
  • E Spackman,
  • L Stirk,
  • A Danso-Appiah,
  • D Suh,
  • S Palmer,
  • A Eastwood

DOI
https://doi.org/10.3310/hta15suppl1/04
Journal volume & issue
Vol. 15, no. Suppl 1

Abstract

Read online

No abstracts available.